Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02000596
Title Trastuzmab and Pertuzumab Alone or in Combination With Hormonal Therapy or Chemotherapy With Eribulin in Women Aged 60 and Over With HER2/Neu Overexpressed Locally Advanced or MBC
Recruitment Terminated
Gender female
Phase Phase II
Variant Requirements No
Sponsors Katherine Tkaczuk
Indications
Therapies
Age Groups: senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Maryland Marlene & Stewart Greenebaum Cancer Center Baltimore Maryland 21201 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field